The therapeutic promises of Lianhuaqingke in the mice model of coronavirus pneumonia (HCoV-229E and SARS-CoV-2).

Mingye WangWenyan LiWenwen CuiYuanyuan HaoYao MiHongtao WangYun-Long HouZhenhua Jia

Published in: Chinese medicine (2021)

Our results demonstrate that LHQK exerts therapeutic effects on pneumonia caused by HCoVs (HCoV-229E and SARS-CoV-2) in mice, and that the anti-HCoV effects might depend on its immunomodulatory capacities. All these results suggest that LHQK serves as a potential adjuvant for anti-HCoV therapies.

Keyphrases

sars cov
respiratory syndrome coronavirus
high fat diet induced
intensive care unit
wild type
respiratory failure
skeletal muscle
coronavirus disease
extracorporeal membrane oxygenation